DE307975C - - Google Patents
Info
- Publication number
- DE307975C DE307975C DENDAT307975D DE307975DA DE307975C DE 307975 C DE307975 C DE 307975C DE NDAT307975 D DENDAT307975 D DE NDAT307975D DE 307975D A DE307975D A DE 307975DA DE 307975 C DE307975 C DE 307975C
- Authority
- DE
- Germany
- Prior art keywords
- milk
- cow
- cows
- antibodies
- serum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000013336 milk Nutrition 0.000 claims description 34
- 239000008267 milk Substances 0.000 claims description 34
- 210000004080 milk Anatomy 0.000 claims description 34
- 241000283690 Bos taurus Species 0.000 claims description 29
- 241000304886 Bacilli Species 0.000 claims description 18
- 239000000427 antigen Substances 0.000 claims description 18
- 102000036639 antigens Human genes 0.000 claims description 18
- 108091007433 antigens Proteins 0.000 claims description 18
- 230000003053 immunization Effects 0.000 claims description 14
- 238000002649 immunization Methods 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 13
- 238000002360 preparation method Methods 0.000 claims description 8
- 201000008827 tuberculosis Diseases 0.000 claims description 8
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 7
- 230000028327 secretion Effects 0.000 claims description 5
- 210000004907 gland Anatomy 0.000 claims description 3
- 230000036039 immunity Effects 0.000 claims description 3
- 210000002966 serum Anatomy 0.000 description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 244000309466 calf Species 0.000 description 8
- 238000002255 vaccination Methods 0.000 description 8
- 210000005075 mammary gland Anatomy 0.000 description 7
- 238000012360 testing method Methods 0.000 description 7
- 238000002347 injection Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000003053 toxin Substances 0.000 description 6
- 231100000765 toxin Toxicity 0.000 description 6
- 235000013365 dairy product Nutrition 0.000 description 5
- 239000012153 distilled water Substances 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 4
- 230000001413 cellular effect Effects 0.000 description 4
- 230000007969 cellular immunity Effects 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000004576 sand Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 229960001005 tuberculin Drugs 0.000 description 3
- 102000009027 Albumins Human genes 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 235000020247 cow milk Nutrition 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 235000004252 protein component Nutrition 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- 238000009631 Broth culture Methods 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000002365 anti-tubercular Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1289—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Mycobacteriaceae (F)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE307975C true DE307975C (en, 2012) |
Family
ID=561272
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DENDAT307975D Active DE307975C (en, 2012) |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE307975C (en, 2012) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1022356B (de) * | 1955-04-07 | 1958-01-09 | Berry Campbell | Verfahren zur Herstellung eines spezifischen Schutzstoffes gegen ein Antigen |
| US4732757A (en) * | 1978-02-06 | 1988-03-22 | Stolle Research And Development Corporation | Prevention and treatment of rheumatoid arthritis |
| USRE33565E (en) * | 1978-02-06 | 1991-04-02 | Stolle Research And Development Corporation | Prevention and treatment of rheumatioid arthritis |
-
0
- DE DENDAT307975D patent/DE307975C/de active Active
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1022356B (de) * | 1955-04-07 | 1958-01-09 | Berry Campbell | Verfahren zur Herstellung eines spezifischen Schutzstoffes gegen ein Antigen |
| US4732757A (en) * | 1978-02-06 | 1988-03-22 | Stolle Research And Development Corporation | Prevention and treatment of rheumatoid arthritis |
| USRE33565E (en) * | 1978-02-06 | 1991-04-02 | Stolle Research And Development Corporation | Prevention and treatment of rheumatioid arthritis |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69527804T2 (de) | Verfahren zum einleiten einer immunantwort bei einem einen tag alten tier | |
| DE3712768C2 (en, 2012) | ||
| DE3712767C2 (en, 2012) | ||
| DE1810438A1 (de) | Prophylaktisches oder therapeutisches Praeparat | |
| DE1720120A1 (de) | Injizierbare Zusatzmittel,Verfahren ihrer Herstellung und Verwendung und neue medizinische Zusammensetzungen,die dieses Zusatzmittel enthalten | |
| DD297331A5 (de) | Verfahren zur herstellung eines impfstoffes | |
| DE3686158T2 (de) | Impfstoff gegen mastitis. | |
| DE307975C (en, 2012) | ||
| DE60216906T2 (de) | Anti-pilyrosporum ovale igy und dessen verwendung | |
| DE1198489B (de) | Verfahren zur Herstellung eines Impfstoffes gegen Panleucopenie | |
| DE2010788A1 (de) | Wasserunlösliche Substanzen mit Antigenwirkung und Verfahren zu ihrer Herstellung | |
| AT85945B (de) | Verfahren zur Gewinnung von Tuberkulose-Immunmilch von Kühen. | |
| DE69231724T2 (de) | Fischimpfstoff gegen infektion mit aeromonas salmonicida | |
| DE60025945T2 (de) | Herstellung von antikörpern in mammarsekreten von zuchttieren | |
| DE3750725T2 (de) | GEMEINSAME IMPFUNG UNTER VERWENDUNG EINER PRAPARATION GRAM-NEGATIVER BAKTERIEN OHNE O-SPEZIFISCHEN KOHlEHYDRATSEITENKETTEN. | |
| DE2134930A1 (de) | Antigene Extrakte | |
| DE261702C (en, 2012) | ||
| DE2626350C2 (de) | Impfstoff | |
| DE2141901A1 (de) | Verfahren zur Herstellung eines Vak zins | |
| DE3028248A1 (de) | Emulgierte antigenzubereitung aus bacteroides nodosus und aluminiumadjuvans und ihre verwendung als impfstoff | |
| DE2225548A1 (de) | Intravenoes vertraegliche staupe- und hepatitisvaccine | |
| DE739594C (de) | Verfahren zur Herstellung eines Heil- und Schutzserums gegen Staupe | |
| DE2817144A1 (de) | Verfahren zur herstellung von nicht immunogenen biologisch aktiven enzymatischen praeparaten aus unloeslichen proteinen | |
| DE2951412A1 (de) | Verfahren zur herstellung immunologisch reaktiver praeparate | |
| DE1902590C2 (de) | Verwendung einer Immunribonucleinsäure (IRNS) zum Immunisieren lebender Tiere |